Digital Monitoring for Patients Post Coronary Interventions to Reduce Risk for Recurrent Adverse Cardiovascular Events

Sponsor
University of California, Davis (Other)
Overall Status
Recruiting
CT.gov ID
NCT06114615
Collaborator
(none)
200
1
2
11
18.2

Study Details

Study Description

Brief Summary

The study aims to support patients immediately after PCI by implementing a telemonitoring program. Eligible patients have coronary heart disease and undergo PCI. The intervention group receives remote monitoring and text-based follow-up, with established health goals and education on using the telemonitoring application, along with necessary devices. The control group gets standard care. Outcomes measured include blood pressure, LDL levels, patient satisfaction, revascularization, and mortality. The study findings will enhance patient care after PCI and contribute evidence for widespread telemonitoring implementation in healthcare systems, aiding medical therapy and lifestyle modifications.

Condition or Disease Intervention/Treatment Phase
  • Device: LiveCare
  • Behavioral: Text Messages
  • Other: Conventional Care
N/A

Detailed Description

The study involves 200 participants divided into intervention and control groups, all diagnosed with coronary heart disease and treated with PCI. Upon discharge, the intervention group receives remote monitoring, text messages, and devices for self-management. Control group receives standard care. Recruitment is from cardiology and primary care clinics, with interpreters available. Study coordinator guides device setup during enrollment. Intervention group receives daily messages for a week, then weekly reminders and counseling. Messages are in English or Spanish as per preference. Patient data is collected, including demographics, medications, and outcomes such as blood pressure and readmission rates. Satisfaction is evaluated through surveys and interviews.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
200 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
None (Open Label)
Primary Purpose:
Supportive Care
Official Title:
Digital Monitoring for Patients Post Coronary Interventions to Reduce Risk for Recurrent Adverse Cardiovascular Events
Anticipated Study Start Date :
Nov 10, 2023
Anticipated Primary Completion Date :
Jun 10, 2024
Anticipated Study Completion Date :
Oct 10, 2024

Arms and Interventions

Arm Intervention/Treatment
Active Comparator: Discharged with LiveCare and Text Message Intervention

Patients receive blood pressure monitoring and text messages reminders for enrollment in cardiac rehab, follow up appointment, diet and exercise counseling.

Device: LiveCare
Patient use LiveCare device to monitor their blood pressure and data is transmitted to dashboard.
Other Names:
  • Blood Pressure and Weight Monitoring
  • Behavioral: Text Messages
    Patients also receive text messages after their PCI procedure for follow up appointment reminders, enrollment in cardiac rehab, and diet and exercise counseling.

    Sham Comparator: Discharged with Conventional Care

    Patients do not receive blood pressure monitoring and text messages reminders for enrollment in cardiac rehab, follow up appointment, diet and exercise counseling.

    Other: Conventional Care
    No digital monitoring with LiveCare device and no text messages.

    Outcome Measures

    Primary Outcome Measures

    1. blood pressure, systolic and diastolic [1 month, 6 months]

    2. readmission rate [1 month, 6 months]

    3. enrollment rate in cardiac rehabilitation [1 month, 6 months]

    4. rate of non-compliance to medications prescribed at discharge [1 month, 6 months]

    5. average ratings on the telehealth usability questionnaire [six months]

      assess patient satisfaction with the teleheath program with 12 questions, each 1-7 points. Total of 84 points; higher score indicates greater satisfaction

    6. patient rate of first follow up appointment [1 month, 6 month]

    Secondary Outcome Measures

    1. lipid profile [one month, six months]

    2. MACE (major adverse cardiovascular events) [one month, six months]

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    N/A and Older
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:
    • Includes patients with coronary heart disease diagnosis and treatment with PCI who follow up at UC Davis Health.

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 University of California, Davis Medical Center Division of Cardiovascular Medicine Sacramento California United States 95817

    Sponsors and Collaborators

    • University of California, Davis

    Investigators

    None specified.

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    University of California, Davis
    ClinicalTrials.gov Identifier:
    NCT06114615
    Other Study ID Numbers:
    • 1972752
    First Posted:
    Nov 2, 2023
    Last Update Posted:
    Nov 2, 2023
    Last Verified:
    Aug 1, 2023
    Individual Participant Data (IPD) Sharing Statement:
    No
    Plan to Share IPD:
    No
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    Yes
    Keywords provided by University of California, Davis
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Nov 2, 2023